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To evaluate the effects of storage conditions on total protein (TP) and globulin fractions in fresh frozen bovine plasmaunits prepared
and stored for transfusion, TP and globulin fractions were evaluated in fresh plasma and at 1 month and 6 and 12 months after
blood collection in plasma stored at −20∘C. Significant differences in concentrations were found in the median concentration of
total protein (𝑃 = 0.0336), between 0 months and 1 month (𝑃 = 0.0108), 0 and 6 months (𝑃 = 0.0023), and 0 and 12 months
(𝑃 = 0.0027), in mean concentration (g/dL) of albumin (𝑃 = 0.0394), between 0months and 1 month (𝑃 = 0.0131), 0 and 6months
(𝑃 = 0.0035), and 0 and 12 months (𝑃 = 0.0038), and beta-2 fraction (𝑃 = 0.0401), between 0 and 6 months (𝑃 = 0.0401) and
0 and 12 months (𝑃 = 0.0230). This study suggests that total gamma globulin concentration in bovine frozen plasma is stable for
12 months at −20∘C. Total protein, ALB, and beta-2 fraction have significantly different concentrations (g/dL) when compared to
prestorage. This study has shown IgG protein fraction stability in bovine fresh frozen plasma collected for transfusion; therefore,
bovine fresh frozen plasma seems to be suitable for the treatment of hypogammaglobulinemia (failure of passive transfer) in calves
when stored for 12 months at −20∘C.
1. Introduction
Fractionated blood products in farm animal transfusion
medicine include packed RBCs, platelet-rich plasma (PRP),
leukocyte-rich plasma, normal bovine plasma, and hyperim-
mune serum. Of these, only two are frequently used in cows
and are bovine plasma and hyperimmune serum [1, 2].
In ruminant transfusion practice, fresh frozen plasma
(FFP) can be used for treatment of hypogammaglobulinemia
(failure of passive transfer) in calves [3, 4]. Calves are born
hypogammaglobulinemic and require colostrum to supply
immunoglobulins during the neonatal period. Neonatal calf
health is largely dependent on the ingestion and absorption
of maternally derived antibodies via colostrum consumption
[5]. Failure of passive transfer (inadequate circulating IgG
concentration) in calves is a common condition that predis-
poses calves to increased morbidity and mortality and there
is a link between low serum globulins and the incidence
of infectious diseases [6]. The importance of the ingestion
and absorption of colostral immunoglobulins on morbidity,
mortality, growth, and future productivity of dairy calves has
been described [7]. Calves with inadequate passive transfer
of colostral immunoglobulins have an increased risk of death
during the first 3 months after birth [8], a decreased rate of
weight gain [9], and a decreased survival rate until the end of
the first lactation [10, 11].
Many studies that have evaluated bovine serum adminis-
tration have shown this to be an effective source of exogenous
passive Ig for newborn calves [2, 5, 6, 12–15].
In dogs and mice plasma proteins appear to be stable
during storage when frozen [16, 17]. Previous studies showed
that there was no significant change in total protein and glob-
ulin fractions, compared with baseline values, in samples of
frozen animal plasma stored for up to 7 days [16–18]. Most of
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these studies, however, were carried out on plasma obtained
from blood, which had been collected using a needle and
syringe, and transferred into lithium-heparin tubes. These
conditions are quite different from those used for preparation
of plasma intended for transfusion purposes which is typi-
cally separated from blood collected using a closed system
into bags containing citrate-phosphate-dextrose-adenine-1
(CPDA-1) anticoagulant and stored in plastic bags at −20∘C.
Furthermore, there is a lack of information about the protein
stability of frozen bovine plasma.
The aim of this study was to evaluate if the bovine
plasma obtained with anticoagulant CPDA-1 could be elec-
trophoresed and to evaluate the effects of storage conditions
on TP and globulin fractions in fresh frozen bovine plasma
units prepared and stored for use in transfusion.
2. Materials and Methods
2.1. Blood Collection. This prospective study was performed
as an internal quality control at the Veterinary Trans-
fusion Unit Blood Bank of University of Milan (REV).
Blood was collected from 20 healthy lactating adult Hol-
stein Friesian donors. Before and after blood collection
all cows were given a standard physical examination [19].
A total volume of 4 L of blood was collected from each
cow. The protocol for this study was approved by the
Institutional Ethical Committee for Animal Care at Uni-
versity of Milan (http://www.unimi.it/cataloghi/comitato
etico/CE 19dic2012 verbale.pdf). A closed-collection system
was used, consisting of sterile human 450mL blood bags
(TERUMO CPDA-1 triple blood bag, GRIFOLS, Italy)
containing 20mL of citrate-phosphate-dextrose-adenine-1
(CPDA-1) anticoagulant, used to collect blood from each
cow. From each cow 8 bags of whole blood were collected.
Whole blood was collected in a standard fashion from
each cow by jugular venipuncture, using a 16-gauge needle
attached to a triple-bag closed-collection system on a blood
mixer. The closed-collection system consisted of a primary
bag containing 63mL of citrate phosphate-double dextrose
solution as anticoagulant, an additive bag that contained
100mL of additive solution (SAG-Mannitol), and 1 empty
satellite bag.
Sterile 450mL whole blood bags were centrifuged in
refrigerated centrifuge (ROTIXA 50RS, Hettich, Germany)
at 900 g for 15 minutes at 4∘C. A manual plasma extractor
(Separation Stand Teruflex ACS-201, United States) was then
used to immediately generate 1 bag of 300mL of plasma from
each unit of blood. Small hand sealer clips were used to create
4 segments of tubing that each contained approximately 1mL
of plasma for each satellite bag.
One segment was used immediately as fresh plasma to
obtain the baseline concentrations of plasma total protein
(TP) and albumin (ALB) concentrations and plasma protein
electrophoresis. Both bags of plasma and the remaining
segments were immediately frozen at −20∘C and stored in a
controlled-temperature blood bank refrigerator (EMOTECA
250, Fiocchetti CO., Italy), where the temperature was con-
sistently maintained at −20∘C.
Plasma samples for all analyses were taken from tubing
segments at 1 month and 6 and 12 months; after blood
collection, one segment for each bag of plasma was thawed
at room temperature (37∘C).
2.2. Analytic Procedures. Total protein and ALB concentra-
tion and plasma protein fractions were determined for each
fresh aliquot and for each frozen aliquot thawed after 1
month and 6 and 12 months of storage. Total protein plasma
concentration wasmeasured by spectrophotometry using the
colorimetric biuretmethod (previously validated for bovines)
[20] on a Cobas Mira Classics Roche automated chemistry
analyzer (Roche S.p.A., Mannheim, Germany; within-run
precision 0.48%; between-run precision 0.88%) that required
10 𝜇L of plasma. Commercial multiparameter human sera
were used to calibrate the machine and to act as controls
(Calibrator and Control Serum, Ben Srl, Milan, Italy). Plasma
albumin concentration was measured by spectrophotometry
using BCG colorimetric method (previously validated for
bovines) [20] on a Cobas Mira Classics Roche automated
chemistry analyzer (Roche S.p.A., Mannheim, Germany;
within-run precision 1.65%; between-run precision 0.96%)
with 10 𝜇L of plasma.
Protein fractions were analyzed using a semiautomatic
agarose gel electrophoresis (AGE) system (Hydrasys, Sebia
PN 1210, Issy-les-Moulineaux, France) (previously validated
for bovine). Plasma was electrophoresed for 7 minutes at 33-
volt hours and stained with diluted Amidoschwarz dye at pH
2 (4 g/L Amidoschwarz dye and 6.7% ethylene glycol). The
AGE procedure was performed according to the manufac-
turer’s instructions, and commercial human serum was used
as the control (normal control serum, Sebia, Evry, France).
Using the computer software Phoresis for Windows 2000 or
XP Pro (Sebia), the electrophoretic curve for each sample was
displayed. Protein fractions were determined based on the
different percentage of optical absorbance and the absolute
concentration in g/dL was automatically calculated from
the total serum protein concentration. The same operator
analyzed all samples. Albumin to globulin (A/G) ratios were
also calculated.Thepercentage of variation observed between
mean values of proteins analyzed in fresh and frozen/thawed
sera was calculated for each protein fraction.
2.3. Statistical Analyses. The data distribution was evaluated
with D’Agostino Pearson normality test. The Kruskal-Wallis
test and paired 𝑡-test or the Mann-Whitney 𝑈 test were
used to compare results for fresh and frozen plasma at the
different times of storage (MedCalc Software, version 12.7.8.0,
Mariakerke, Belgium). Significance was set at 𝑃 < 0.05.
3. Results
Albumin, alpha-1 fraction, expressed in g and as %, and
A/G ratio were normally distributed. Mean, median, and
95% confidence interval of concentrations of total protein
and ALB and alpha-1, alpha-2, beta-1, beta-2, and gamma
globulin fractions concentrations, evaluated at different time
of storage, are reported in Table 1. Concentrations (g/dL) of
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Table 1:Mean,median, and confidence interval 95% (95%CI) of total protein (TP) concentrations (biuretmethod), concentrations of albumin
(ALB) and alpha-1, alpha-2, beta-1, beta-2, and gammaglobulin fractions (agarose gel electrophoresis), and calculated albumin/globulin (A/G)
ratios in fresh plasma samples and plasma samples stored frozen (−20∘C) and then thawed, collected from 20 adult cows for transfusion
purposes.
Storage
time (months)
TP
g/dL
(95% CI)
ALB
g/dL
(95% CI)
Alpha-1
g/dL
(95% CI)
Alpha-2
g/dL
(95% CI)
Beta-1
g/dL
(95% CI)
Beta-2
g/dL
(95% CI)
Gamma
g/dL
(95% CI)
A/G
0 7(6.8–7.1)
3.07
(2.9–3.2)
0.27
(0.24–0.30)
0.37
(0.34–0.38)
0.27
(0.26–0.28)
0.53
(0.48–0.57)
2.97
(2.8–3.06)
0.6
(0.53–0.65)
1 7.45(6.8–7.9)
3.02
(2.8–3.1)
0.28
(0.26–0.31)
0.37
(0.33–0.41)
0.29
(0.25–0.31)
0.55
(0.50–0.60)
3.02
(2.72–3.59)
0.61
(0.53–0.70)
6 7.45(7.1–7.8)
3.09
(2.9–3.2)
0.26
(0.23–0.29)
0.37
(0.34–0.42)
0.29
(0.27–0.30)
0.57
(0.53–0.64)
3.16
(2.87–3.33)
0.63
(0.55–0.70)
12 7.25(7.1–7.5)
3.3
(3.1–3.4)
0.28
(0.25–0.31)
0.37
(0.36–0.40)
0.31
(0.29–0.32)
0.6
(0.53–0.70)
3.11
(2.77–3.33)
0.61
(0.54–0.68)
Table 2: Effects of storage time on protein parameters in bovine plasma obtained for transfusion purposes and stored frozen at −20∘C for 12
months. Mean, median, 𝑃 value (referred to Kruskal-Wallis (K-W) test and paired 𝑡-test or Mann-Whitney (M-W) test), and percentage of
variation in total protein (TP), albumin (ALB), and beta-2 globulin fractions (agarose gel electrophoresis) at different time of storage.
Sample Time (months)
𝑃 value
P. 𝑡-test
M-W
𝑃 value
K-W Mean/median difference Percentage of variation %
TP 0-1 0.0108
0.0336
7–7.45 g/dL 6.4%
TP 0–6 0.0023 7–7.45 g/dL 6.4%
TP 0–12 0.0027 7–7.25 g/dL 3.5%
ALB 0-1 0.0131
0.0394
2.6–2.8 g/dL 7.6%
ALB 0–6 0.0035 2.6–2.8 g/dL 7.6%
ALB 0–12 0.0038 2.6–2.8 g/dL 7.6%
Beta-2 0–6 0.0401 0.0401 0.53–0.57 g/dL 7.5%
Beta-2 0–12 0.0230 0.53–0.60 g/dL 13.2%
TP, ALB, and beta-2 fractions show significantly different
increase from fresh and frozen plasma.
The results indicate that plasma concentrations (g/dL)
of TP and ALB change after 1 month of storage at −20∘C,
whereas concentrations of beta-2 protein fractions were
stable for 6 months at −20∘C.
The significant effects of storage time on mean concen-
tration of TP and on the concentration of protein fractions
with the percentage of variation observed in fresh and
frozen/thawed sera for each protein fraction are reported in
Table 2.
On electropherograms there were 6 protein fractions:
albumin, alpha-1, alpha-2, beta-1, beta-2, and gamma globu-
lins. All samples analyzed at the different time of storage had
comparable electrophoretic patterns (Figure 1).
4. Discussion
There is a paucity of information about serumprotein profiles
in cattle. Most of the data were collected years ago, with
different support media [20–23]. In our study the plasma TP
and ALB and concentrations of protein fractions, obtained
by agarose gel support media, were comparable with those
reported by To´thova´ et al. [24] in a recent study, while
the mean values of alpha globulin and gamma globulins
are, respectively, lower and higher than values reported by
Kaneko [25].
In accordance with other studies [24, 26], agarose-
supporting matrix permitted identification of 6 electropho-
retic bands with good resolution in all fresh and frozen
samples. All samples had similar electropherograms, with
comparable electrophoretic patterns. In our study CPDA-
1 was used as the anticoagulant, while in previous studies
serum or plasma was obtained using lithium-heparin anti-
coagulant. Our results suggest that the type of anticoagulant
does not affect the resolution of the electrophoretic method.
Serum proteins have been reported to remain stable in
storage [16–18]. The effect of duration and temperature of
storage on canine plasma and serum constituents has been
documented [16]. Most analytes show no or verymild change
in canine plasma [16] and concentrations of glucose and
total proteins in human samples have been shown to be
unaffected by repeated freeze-thaw cycles [27]. Our results
concur with results of previous studies that evaluated the
effects of freezing and storage on routine assays of total
protein and protein fractions in other animals [16–18]. In
those studies, however, blood samples were collected by
means of direct venipuncture, using a syringe and needle, and
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Figure 1: Representative serum protein electropherograms using agarose gel electrophoresis in bovine plasma obtained for transfusion
purposes (anticoagulant CPDA-1) in fresh plasma sample and plasma sample stored frozen (−20∘C) for 12 months. Note the appearance
of 6 peaks: albumin (ALB) and alpha-1, alpha-2, beta-1, beta-2, and gamma globulin fractions.
placed in glass or plastic tubes (either empty or containing
lithium-heparin), conditions which do not mimic those used
for obtaining and storing plasma for transfusion.
In our study, when the value of protein fractions was
expressed as a percentage of TP, no difference was found
between fresh plasma and thawed plasma at any storage time.
However, when the values were expressed in g/dL, significant
differences were seen, with a number of analytes occurring
at higher concentrations in frozen/thawed serum than in
fresh serum, for example, mean concentration of TP between
0 months and 1 month (6,4%), 0 and 6 months (6.4%),
and 0 and 12 months (3.5%); ALB concentration between 0
months and 1 month, 0 and 6 months, and 0 and 12 months
(7.6%); and beta-2 concentration between 0 and 6 months
and 0 and 12 months (7.5% and 13.2%, resp.). Reynolds et al.
[17] reported similar results in a study examining effects on
canine plasma protein after repeated freeze-thaw cycles. In
our study the change in the mean values exceeded “accepted
value of within subject biological variation” and “total error
allowed for people” [28], and in the case of beta globulin the
percentage of variation exceeded 10%. In accordance with the
interpretation of Cray et al. [18] we accepted that differences
greater than 10% of the minimal difference are likely to have
clinical significance in the interpretation of the biochemical
analysis.
The comparison of analysis of bovine plasma with human
ranges of biological variation may be erroneous, and without
species-specific ranges of biological variability, definitive
conclusions cannot be drawn. In this study the maximal
percentage of variation observed between fresh and frozen
plasma was not considered clinically relevant and would not
be expected to lead to misinterpretation of the results [17].
Thus, this study demonstrates that in bovine plasma stored
at −20∘C changes in protein fractions occur in TP, ALB,
and beta-2 globulin expressed as g/dL after 1 month and 6
and 12 months. Since one of the main reasons for use of
bovine frozen plasma is the passive transfer of immunity
for treatment of hypogammaglobulinemia in calves, the
preservation of the gamma globulin fraction is essential.
In our study there was no difference between the gamma
globulin fraction expressed as g/dL and the percentage in
fresh and thawed plasma at any time of storage studied. So
bovine fresh frozen plasma seems to be suitable for treatment
of hypogammaglobulinemia (failure of passive transfer of
immunity) in calves when stored for 12 months at −20∘C.
5. Conclusion
This study suggests that total gamma globulin concentration
in bovine frozen plasma is stable for 12 months at −20∘C.
Total protein, ALB, and beta-2 fraction have significantly
different concentrations when expressed as g/dL compared to
prestorage. This study has shown IgG protein fraction stabil-
ity in bovine fresh frozen plasma collected for transfusion;
therefore, bovine fresh frozen plasma seems to be suitable
for treatment of hypogammaglobulinemia (failure of passive
transfer) in calves when stored for 12 months at −20∘C.
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